![[TXT]](/icons/text.gif) 121b.0906-cIMT, an early marker of CVD (Polak, US quartely).pdf | 558.44Kb | June 19 2009 |
| 122.0906-Concomitant CAS and PAD. Relationship between inflammatory status of the affected limb and severity of CAD (Brevetti, jvs).pdf | 516.51Kb | June 19 2009 |
| 131.0905-Effects of Web- and Computer-based smoking cessation programs. MA of RCT (Myung, Arch Int Med)pdf.pdf | 354.42Kb | June 19 2009 |
| 131.0906-Bйnйfices CV du sevrage tabagique (Thomas, Press Med) +++.pdf | 631.80Kb | June 19 2009 |
| 131.0906-Nicotine gum treatment before smoking cessation, RCT (Etter, Arch Int Med).pdf | 303.05Kb | June 19 2009 |
| 133.0907-Cigarette smoking, smoking cessation, and diabetes (Tonstad, Diab Res & Clin Pract).pdf | 412.25Kb | June 19 2009 |
| 134.0906-Narrative review, Statin-related myopathy (Joy, Ann Int Med).pdf | 321.69Kb | June 19 2009 |
| 134.0907-Triglycerides as vascular RF, new epidemiologic insights (Kannel, Curr Opin Cardiol).pdf | 297.55Kb | June 19 2009 |
| 135.0905-Obesity and Cardiovascular disease, RF Paradox and Impact of weight loss (Lavie, jacc).pdf | 582.74Kb | June 19 2009 |
| 140.0906-ACE inhibitor in patients with vascular disease (Pitt, Eur Heart J) Editorial.pdf | 370.60Kb | June 19 2009 |
| 140.0906-Consistency of the Tt effect of ACE-inhibitor based Tt regimen in patients vascular disease or at high risk of vascular disease (Brugts, Eur Heart J).pdf | 523.47Kb | June 19 2009 |
| 141.0905-1 Aspirin in Iary prevention, Collaborative MA of individual participant data from RCT (ATT, Lancet).pdf | 514.51Kb | June 19 2009 |
| 141.0905-2 Aspirin in Iary prevention, sex and baseline risk matter (Algra, Lancet) Comment.pdf | 237.55Kb | June 19 2009 |
| 160.0907-Cardiovascular molecular imaging (Fayad, ATVB).pdf | 430.89Kb | June 19 2009 |
| 160.0907-Inflammation imaging in atherosclerosis (Rudd, ATVB).pdf | 929.24Kb | June 19 2009 |
| 160.0907-Molecular imaging in atherosclerosis, thrombosis and vascular inflammation (Choudhury, ATVB).pdf | 972.35Kb | June 19 2009 |
| 160.0907-Molecular imaging of macrophage, cell death for assessment of plaque vulnerability (Laufer, ATVB).pdf | 1.31Mb | June 19 2009 |
| 223c.0905-TIA patients with fluctuations are at highest risk for early stroke (Hennerici, CVD).pdf | 334.46Kb | June 19 2009 |
| 23.0906-Measurement depth and volume in LDF (Fredriksson, Mircrovasc Research).pdf | 1.06Mb | June 19 2009 |
| 241.0907-Carotid plaque analysis, Comparison of dual-source CT findings and histological correlation (Das, ejves).pdf | 373.34Kb | June 19 2009 |
| 242.0906-Velocity variability in US doppler examinations (Hadlock, USMB).pdf | 355.72Kb | June 19 2009 |
| 252.0906-Who benefits most from intervention for asymptomatic CS, patients or professionals (Naylor, ejves) ++.pdf | 385.31Kb | July 13 2009 |
| 252d.0906-Indications for carotid screening in patients with CAD (Aboyans, Press Med).pdf | 726.01Kb | June 19 2009 |
| 255.0906-LMWH significantly reduces embolisation after CEA, RCT (McMahon, ejves).pdf | 544.34Kb | June 19 2009 |
| 255.0906-Two year FU results of the SAPCE trial (Forbes, jvs).pdf | 221.44Kb | June 19 2009 |
| 262.0907-EC and TC ultrasound assessment in patients with suspected positional VB ischaemia (Sultan, ejves).pdf | 412.45Kb | June 19 2009 |
| 276.0907-Cervical artery dissections, predisposing factors, diagnosis and outcome (Debette, Lancet Neurol) ++.pdf | 633.92Kb | June 19 2009 |
| 316.0906-1 Abnormal skeletal muscle capillary recruitment during exercise in T2 diabetes (Lindner, jacc).pdf | 886.12Kb | June 19 2009 |
| 316.0906-2 Capillary BF abnormalities in the skeletal muscle and microvascular complications in diabetes (Porter, jacc). Editorial.pdf | 243.32Kb | June 19 2009 |
| 317.0906-PAD and Virchow's triad (Bennett, TH).pdf | 664.86Kb | June 19 2009 |
![[DIR]](/icons/back.gif){kind=icon}
Parent Directory